{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:21:59Z","timestamp":1780510919848,"version":"3.54.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"National University Ireland, Galway"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s40265-023-01899-0","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T12:16:58Z","timestamp":1687609018000},"page":"985-999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Focus on Metformin: Its Role and Safety in Pregnancy and Beyond"],"prefix":"10.1007","volume":"83","author":[{"given":"Christine","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Rabbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adesuwa","family":"Ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelma P.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"1899_CR1","volume-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013."},{"issue":"4","key":"1899_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/dmrr.390","volume":"19","author":"G Di Cianni","year":"2003","unstructured":"Di Cianni G, et al. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev. 2003;19(4):259\u201370.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"1899_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MED.0b013e32834c800d","volume":"18","author":"D Newbern","year":"2011","unstructured":"Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes. 2011;18(6):409\u201316.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"1899_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/0002-9378(90)91306-W","volume":"162","author":"TA Buchanan","year":"1990","unstructured":"Buchanan TA, et al. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 1990;162(4):1008\u201314.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1899_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/dmt.10.24","volume":"1","author":"S Ernst","year":"2011","unstructured":"Ernst S, et al. Mechanisms in the adaptation of maternal \u03b2-cells during pregnancy. Diabetes Manag (Lond). 2011;1(2):239\u201348.","journal-title":"Diabetes Manag (Lond)"},{"issue":"4","key":"1899_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.11.002","volume":"47","author":"H Affres","year":"2021","unstructured":"Affres H, et al. Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure. Diabetes Metab. 2021;47(4): 101210.","journal-title":"Diabetes Metab"},{"issue":"19","key":"1899_CR7","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358(19):2003\u201315.","journal-title":"N Engl J Med"},{"issue":"10","key":"1899_CR8","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.2337\/dc11-0660","volume":"34","author":"JA Rowan","year":"2011","unstructured":"Rowan JA, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age. Diabetes Care. 2011;34(10):2279\u201384.","journal-title":"Diabetes Care"},{"key":"1899_CR9","doi-asserted-by":"publisher","unstructured":"Fox R, et al. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019;8(10):1625. https:\/\/doi.org\/10.3390\/jcm8101625.","DOI":"10.3390\/jcm8101625"},{"issue":"3","key":"1899_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11892-015-0579-4","volume":"15","author":"TL Weissgerber","year":"2015","unstructured":"Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Curr Diab Rep. 2015;15(3):9.","journal-title":"Curr Diab Rep"},{"key":"1899_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.831297","volume":"9","author":"Y Yang","year":"2022","unstructured":"Yang Y, Wu N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front Cardiovasc Med. 2022;9: 831297.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"1899_CR12","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.ajog.2004.03.074","volume":"191","author":"Y Yogev","year":"2004","unstructured":"Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. 2004;191(5):1655\u201360.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1899_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tjog.2015.08.024","volume":"55","author":"D Boriboonhirunsarn","year":"2016","unstructured":"Boriboonhirunsarn D, Waiyanikorn R. Emergency cesarean section rate between women with gestational diabetes and normal pregnant women. Taiwan J Obstet Gynecol. 2016;55(1):64\u20137.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1899_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/IJWH.S26094","volume":"3","author":"A Bener","year":"2011","unstructured":"Bener A, Saleh NM, Al-Hamaq A. Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons. Int J Womens Health. 2011;3:367\u201373.","journal-title":"Int J Womens Health"},{"key":"1899_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.diabres.2017.12.003","volume":"136","author":"D Bogdanet","year":"2018","unstructured":"Bogdanet D, et al. ATLANTIC DIP: Despite insulin therapy in women with IADPSG diagnosed GDM, desired pregnancy outcomes are still not achieved. What are we missing? Diabetes Res Clin Pract. 2018;136:116\u201323.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1899_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4239\/wjd.v6.i2.234","volume":"6","author":"E Noctor","year":"2015","unstructured":"Noctor E, Dunne FP. Type 2 diabetes after gestational diabetes: the influence of changing diagnostic criteria. World J Diabetes. 2015;6(2):234\u201344.","journal-title":"World J Diabetes"},{"issue":"4","key":"1899_CR17","doi-asserted-by":"publisher","first-page":"E744","DOI":"10.1210\/jc.2012-3324","volume":"98","author":"SH Kwak","year":"2013","unstructured":"Kwak SH, et al. Clinical and genetic risk factors for type 2 diabetes at early or late post partum after gestational diabetes mellitus. J Clin Endocrinol Metab. 2013;98(4):E744\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1899_CR18","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","volume":"25","author":"C Kim","year":"2002","unstructured":"Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862\u20138.","journal-title":"Diabetes Care"},{"issue":"6","key":"1899_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1530\/EJE-11-0663","volume":"165","author":"MW O'Reilly","year":"2011","unstructured":"O\u2019Reilly MW, et al. Atlantic DIP: high prevalence of abnormal glucose tolerance post partum is reduced by breast-feeding in women with prior gestational diabetes mellitus. Eur J Endocrinol. 2011;165(6):953\u20139.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1899_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jamainternmed.2014.1795","volume":"174","author":"W Bao","year":"2014","unstructured":"Bao W, et al. Physical activity and sedentary behaviors associated with risk of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort study. JAMA Intern Med. 2014;174(7):1047\u201355.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1899_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","volume":"62","author":"CK Kramer","year":"2019","unstructured":"Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62(6):905\u201314.","journal-title":"Diabetologia"},{"issue":"7","key":"1899_CR22","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2337\/dc11-0268","volume":"34","author":"DK Tobias","year":"2011","unstructured":"Tobias DK, et al. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care. 2011;34(7):1582\u20134.","journal-title":"Diabetes Care"},{"issue":"1","key":"1899_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000870","volume":"8","author":"G Chodick","year":"2020","unstructured":"Chodick G, et al. Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study. BMJ Open Diabetes Res Care. 2020;8(1): e000870.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"10","key":"1899_CR24","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/CIRCULATIONAHA.120.047320","volume":"143","author":"EP Gunderson","year":"2021","unstructured":"Gunderson EP, et al. Gestational diabetes history and glucose tolerance after pregnancy associated with coronary artery calcium in women during midlife: the CARDIA study. Circulation. 2021;143(10):974\u201387.","journal-title":"Circulation"},{"issue":"4","key":"1899_CR25","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1210\/jc.2014-4474","volume":"100","author":"O Beharier","year":"2015","unstructured":"Beharier O, et al. Gestational diabetes mellitus is a significant risk factor for long-term maternal renal disease. J Clin Endocrinol Metab. 2015;100(4):1412\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"1899_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101294","volume":"45","author":"J Fu","year":"2022","unstructured":"Fu J, Retnakaran R. The life course perspective of gestational diabetes: an opportunity for the prevention of diabetes and heart disease in women. EClinicalMedicine. 2022;45: 101294.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"1899_CR27","first-page":"733","volume":"35","author":"A Malinowska-Polubiec","year":"2014","unstructured":"Malinowska-Polubiec A, et al. Shoulder dystocia in diabetic and non-diabetic pregnancies. Neuro Endocrinol Lett. 2014;35(8):733\u201340.","journal-title":"Neuro Endocrinol Lett"},{"issue":"7","key":"1899_CR28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2337\/dc18-0048","volume":"41","author":"DN Voormolen","year":"2018","unstructured":"Voormolen DN, et al. Neonatal hypoglycemia following diet-controlled and insulin-treated gestational diabetes mellitus. Diabetes Care. 2018;41(7):1385\u201390.","journal-title":"Diabetes Care"},{"issue":"11","key":"1899_CR29","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1055\/s-0037-1604414","volume":"34","author":"T Kawakita","year":"2017","unstructured":"Kawakita T, et al. Increased neonatal respiratory morbidity associated with gestational and pregestational diabetes: a retrospective study. Am J Perinatol. 2017;34(11):1160\u20138.","journal-title":"Am J Perinatol"},{"issue":"10","key":"1899_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.2018.11628","volume":"320","author":"WL Lowe Jr","year":"2018","unstructured":"Lowe WL Jr, et al. Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity. JAMA. 2018;320(10):1005\u201316.","journal-title":"JAMA"},{"issue":"4","key":"1899_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00125-018-4809-6","volume":"62","author":"WL Lowe","year":"2019","unstructured":"Lowe WL, et al. Maternal glucose levels during pregnancy and childhood adiposity in the hyperglycemia and adverse pregnancy outcome follow-up study. Diabetologia. 2019;62(4):598\u2013610.","journal-title":"Diabetologia"},{"issue":"3","key":"1899_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2337\/dc18-2021","volume":"42","author":"DM Scholtens","year":"2019","unstructured":"Scholtens DM, et al. Hyperglycemia and adverse pregnancy outcome follow-up study (HAPO FUS): maternal glycemia and childhood glucose metabolism. Diabetes Care. 2019;42(3):381\u201392.","journal-title":"Diabetes Care"},{"issue":"11","key":"1899_CR33","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1007\/s00125-014-3345-2","volume":"57","author":"T Holder","year":"2014","unstructured":"Holder T, et al. A low disposition index in adolescent offspring of mothers with gestational diabetes: a risk marker for the development of impaired glucose tolerance in youth. Diabetologia. 2014;57(11):2413\u201320.","journal-title":"Diabetologia"},{"issue":"2","key":"1899_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2337\/dc07-1596","volume":"31","author":"TD Clausen","year":"2008","unstructured":"Clausen TD, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340\u20136.","journal-title":"Diabetes Care"},{"issue":"2","key":"1899_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ajh.2008.326","volume":"22","author":"CS Wright","year":"2009","unstructured":"Wright CS, et al. Intrauterine exposure to gestational diabetes, child adiposity, and blood pressure. Am J Hypertens. 2009;22(2):215\u201320.","journal-title":"Am J Hypertens"},{"issue":"5","key":"1899_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2337\/dc16-2397","volume":"40","author":"WH Tam","year":"2017","unstructured":"Tam WH, et al. In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring. Diabetes Care. 2017;40(5):679\u201386.","journal-title":"Diabetes Care"},{"issue":"14","key":"1899_CR37","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/jama.2015.2707","volume":"313","author":"AH Xiang","year":"2015","unstructured":"Xiang AH, et al. Association of maternal diabetes with autism in offspring. JAMA. 2015;313(14):1425\u201334.","journal-title":"JAMA"},{"key":"1899_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2147\/NDT.S189200","volume":"15","author":"L Zhao","year":"2019","unstructured":"Zhao L, et al. The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis. Neuropsychiatr Dis Treat. 2019;15:675\u201384.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"1899_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12887-019-1509-4","volume":"19","author":"L-X Qiao","year":"2019","unstructured":"Qiao L-X, et al. Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia. BMC Pediatr. 2019;19(1):133.","journal-title":"BMC Pediatr"},{"issue":"Suppl 1","key":"1899_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00003495-199958001-00009","volume":"58","author":"NF Wiernsperger","year":"1999","unstructured":"Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs. 1999;58(Suppl 1):31\u20139 (discussion 75\u201382).","journal-title":"Drugs"},{"issue":"5","key":"1899_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0006-291X(02)02565-2","volume":"298","author":"N Yasuda","year":"2002","unstructured":"Yasuda N, et al. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. Biochem Biophys Res Commun. 2002;298(5):779\u201384.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1899_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2165\/00003495-199549050-00007","volume":"49","author":"CJ Dunn","year":"1995","unstructured":"Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs. 1995;49(5):721\u201349.","journal-title":"Drugs"},{"issue":"2","key":"1899_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","volume":"50","author":"GG Graham","year":"2011","unstructured":"Graham GG, et al. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 2011;50(2):81\u201398.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"1899_CR44","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1124\/dmd.109.031245","volume":"38","author":"S Eyal","year":"2010","unstructured":"Eyal S, et al. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos. 2010;38(5):833\u201340.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1899_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1464-5491.2005.01769.x","volume":"23","author":"RC Hughes","year":"2006","unstructured":"Hughes RC, et al. Effect of pregnancy on the pharmacokinetics of metformin. Diabet Med. 2006;23(3):323\u20136.","journal-title":"Diabet Med"},{"issue":"1","key":"1899_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1067\/mcp.2003.9","volume":"73","author":"SJ Gardiner","year":"2003","unstructured":"Gardiner SJ, et al. Transfer of metformin into human milk. Clin Pharmacol Ther. 2003;73(1):71\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1899_CR47","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/cpt.1749","volume":"107","author":"DL Shuster","year":"2020","unstructured":"Shuster DL, et al. Pharmacodynamics of glyburide, metformin, and glyburide\/metformin combination therapy in the treatment of gestational diabetes mellitus. Clin Pharmacol Ther. 2020;107(6):1362\u201372.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1899_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/pd.2026","volume":"28","author":"M Kovo","year":"2008","unstructured":"Kovo M, et al. Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model. Prenat Diagn. 2008;28(6):544\u20138.","journal-title":"Prenat Diagn"},{"issue":"7","key":"1899_CR49","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1345\/aph.1K045","volume":"41","author":"DS Feig","year":"2007","unstructured":"Feig DS, Briggs GG, Koren G. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift? Ann Pharmacother. 2007;41(7):1174\u201380.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"1899_CR50","first-page":"179","volume":"10","author":"SJ Gutzin","year":"2003","unstructured":"Gutzin SJ, et al. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis. Can J Clin Pharmacol. 2003;10(4):179\u201383.","journal-title":"Can J Clin Pharmacol"},{"key":"1899_CR51","doi-asserted-by":"crossref","unstructured":"Pu R, Shi D, Gan T, Ren X, Ba Y, Huo Y, Bai Y, Zheng T, Cheng N. Effects of metformin in obesity treatment in different populations: a meta-analysis. Ther Adv Endocrinol Metabl. 2020;11.","DOI":"10.1177\/2042018820926000"},{"issue":"2","key":"1899_CR52","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","volume":"87","author":"R Fleming","year":"2002","unstructured":"Fleming R, et al. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab. 2002;87(2):569\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"1899_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2477","volume":"361","author":"JE Given","year":"2018","unstructured":"Given JE, et al. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ. 2018;361: k2477.","journal-title":"BMJ"},{"key":"1899_CR54","doi-asserted-by":"crossref","unstructured":"Sharpe A, M L, Tang T, Norman RJ, Balen AH. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Rev. 2019;2019(12).","DOI":"10.1002\/14651858.CD013505"},{"issue":"5","key":"1899_CR55","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1370\/afm.343","volume":"3","author":"KM Levri","year":"2005","unstructured":"Levri KM, et al. Metformin as treatment for overweight and obese adults: a systematic review. Ann Fam Med. 2005;3(5):457\u201361.","journal-title":"Ann Fam Med"},{"issue":"1","key":"1899_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(18)30310-3","volume":"7","author":"JM Dodd","year":"2019","unstructured":"Dodd JM, et al. Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(1):15\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"1899_CR57","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","volume":"3","author":"C Chiswick","year":"2015","unstructured":"Chiswick C, et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2015;3(10):778\u201386.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1899_CR58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434\u201343.","journal-title":"N Engl J Med"},{"key":"1899_CR59","unstructured":"Rasquin Leon LI, Anastasopoulou C, Mayrin JV. Polycystic ovarian disease, in StatPearls. StatPearls Publishing Copyright \u00a9 2022. Treasure Island: StatPearls Publishing LLC.; 2022"},{"key":"1899_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d6309","volume":"343","author":"N Roos","year":"2011","unstructured":"Roos N, et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ. 2011;343: d6309.","journal-title":"BMJ"},{"key":"1899_CR61","doi-asserted-by":"crossref","unstructured":"Liu S, et al. Pregnancy outcomes of women with polycystic ovary syndrome for the first in vitro fertilization treatment: a retrospective cohort study with 7678 patients. Front Endocrinol. 2020;11.","DOI":"10.3389\/fendo.2020.575337"},{"issue":"10","key":"1899_CR62","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3109\/09513590.2010.540600","volume":"27","author":"S Khattab","year":"2011","unstructured":"Khattab S, et al. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study Gynecol Endocrinol. 2011;27(10):789\u201393.","journal-title":"Prospective cohort study. Gynecol Endocrinol"},{"issue":"3","key":"1899_CR63","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","volume":"77","author":"CJ Glueck","year":"2002","unstructured":"Glueck CJ, et al. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril. 2002;77(3):520\u20135.","journal-title":"Fertil Steril"},{"issue":"2","key":"1899_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1447-0756.2008.00876.x","volume":"35","author":"MR Begum","year":"2009","unstructured":"Begum MR, et al. Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res. 2009;35(2):282\u20136.","journal-title":"J Obstet Gynaecol Res"},{"issue":"12","key":"1899_CR65","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1210\/jc.2010-0853","volume":"95","author":"E Vanky","year":"2010","unstructured":"Vanky E, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010;95(12):E448\u201355.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1899_CR66","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS L\u00f8vvik","year":"2019","unstructured":"L\u00f8vvik TS, et al. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2019;7(4):256\u201366.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"1899_CR67","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/00365510802254620","volume":"68","author":"KJ Fougner","year":"2008","unstructured":"Fougner KJ, Vanky E, Carlsen SM. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest. 2008;68(8):771\u20136.","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"1899_CR68","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/humrep\/deh347","volume":"19","author":"E Vanky","year":"2004","unstructured":"Vanky E, et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod. 2004;19(8):1734\u201340.","journal-title":"Hum Reprod"},{"issue":"4","key":"1899_CR69","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/uog.3965","volume":"29","author":"KA Salvesen","year":"2007","unstructured":"Salvesen KA, Vanky E, Carlsen SM. Metformin treatment in pregnant women with polycystic ovary syndrome\u2013is reduced complication rate mediated by changes in the uteroplacental circulation? Ultrasound Obstet Gynecol. 2007;29(4):433\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"1899_CR70","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1210\/jc.2011-3061","volume":"97","author":"L Morin-Papunen","year":"2012","unstructured":"Morin-Papunen L, et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J Clin Endocrinol Metab. 2012;97(5):1492\u2013500.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1899_CR71","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/09513590.2022.2080194","volume":"38","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, He J. Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials. Gynecol Endocrinol. 2022;38(7):558\u201368.","journal-title":"Gynecol Endocrinol"},{"key":"1899_CR72","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/325851","volume":"2015","author":"JA Ainuddin","year":"2015","unstructured":"Ainuddin JA, et al. Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy. J Diabetes Res. 2015;2015: 325851.","journal-title":"J Diabetes Res"},{"issue":"5","key":"1899_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125712","volume":"10","author":"T Beyuo","year":"2015","unstructured":"Beyuo T, et al. Metformin versus insulin in the management of pre-gestational diabetes mellitus in pregnancy and gestational diabetes mellitus at the Korle Bu Teaching Hospital: a randomized clinical trial. PLoS ONE. 2015;10(5): e0125712.","journal-title":"PLoS ONE"},{"issue":"6","key":"1899_CR74","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1055\/s-0032-1326994","volume":"30","author":"MA Hickman","year":"2013","unstructured":"Hickman MA, et al. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol. 2013;30(6):483\u201390.","journal-title":"Am J Perinatol"},{"issue":"2","key":"1899_CR75","first-page":"163","volume":"30","author":"JS Refuerzo","year":"2015","unstructured":"Refuerzo JS, et al. A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. Am J Perinatol. 2015;30(2):163\u201370.","journal-title":"Am J Perinatol"},{"issue":"12","key":"1899_CR76","first-page":"866","volume":"23","author":"S Waheed","year":"2013","unstructured":"Waheed S, Malik FP, Mazhar SB. Efficacy of metformin versus insulin in the management of pregnancy with diabetes. J Coll Physicians Surg Pak. 2013;23(12):866\u20139.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"1899_CR77","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.diabres.2014.10.001","volume":"107","author":"J Ainuddin","year":"2015","unstructured":"Ainuddin J, et al. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. Diabetes Res Clin Pract. 2015;107(2):290\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1899_CR78","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/2042098618769831","volume":"9","author":"TM Polasek","year":"2018","unstructured":"Polasek TM, Doogue MP, Thynne TRJ. Metformin treatment of type 2 diabetes mellitus in pregnancy: update on safety and efficacy. Therapeutic advances in drug safety. 2018;9(6):287\u201395.","journal-title":"Therapeutic advances in drug safety"},{"issue":"10","key":"1899_CR79","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"Feig DS, et al. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2020;8(10):834\u201344.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"1899_CR80","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1210\/er.2006-0039","volume":"28","author":"P Saenger","year":"2007","unstructured":"Saenger P, et al. Small for gestational age: short stature and beyond. Endocr Rev. 2007;28(2):219\u201351.","journal-title":"Endocr Rev"},{"issue":"8","key":"1899_CR81","doi-asserted-by":"publisher","first-page":"e1002848","DOI":"10.1371\/journal.pmed.1002848","volume":"16","author":"JL Tarry-Adkins","year":"2019","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 2019;16(8):e1002848\u2013e1002848.","journal-title":"PLoS Med"},{"key":"1899_CR82","doi-asserted-by":"publisher","first-page":"9804708","DOI":"10.1155\/2019\/9804708","volume":"2019","author":"L Guo","year":"2019","unstructured":"Guo L, et al. Comparative efficacy and safety of metformin, glyburide, and insulin in treating gestational diabetes mellitus: a meta-analysis. J Diabetes Res. 2019;2019:9804708.","journal-title":"J Diabetes Res"},{"issue":"5","key":"1899_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003126","volume":"17","author":"JL Tarry-Adkins","year":"2020","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: a systematic review and meta-analysis. PLoS Med. 2020;17(5): e1003126.","journal-title":"PLoS Med"},{"issue":"12","key":"1899_CR84","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1210\/jc.2008-0772","volume":"93","author":"RE Ratner","year":"2008","unstructured":"Ratner RE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1899_CR85","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1210\/jc.2014-3761","volume":"100","author":"VR Aroda","year":"2015","unstructured":"Aroda VR, et al. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015;100(4):1646\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1899_CR86","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2337\/dc18-1970","volume":"42","author":"Long-term Effects of Metformin on Diabetes Prevention","year":"2019","unstructured":"Long-term Effects of Metformin on Diabetes Prevention. Identification of subgroups that benefited most in the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care. 2019;42(4):601\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"1899_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107548","volume":"34","author":"KE Elkind-Hirsch","year":"2020","unstructured":"Elkind-Hirsch KE, Shaler D, Harris R. Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight\/obese women with recent gestational diabetes: a double-blind, randomized, placebo-controlled study. J Diabetes Complications. 2020;34(4): 107548.","journal-title":"J Diabetes Complications"},{"issue":"3","key":"1899_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100139","volume":"2","author":"KE Elkind-Hirsch","year":"2020","unstructured":"Elkind-Hirsch KE, Seidemann E, Harris R. A randomized trial of dapagliflozin and metformin, alone and combined, in overweight women after gestational diabetes mellitus. Am J Obstet Gynecol MFM. 2020;2(3): 100139.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"1","key":"1899_CR89","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2021-002363","volume":"10","author":"KMG Brand","year":"2022","unstructured":"Brand KMG, et al. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. BMJ Open Diabetes Res Care. 2022;10(1): e002363.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"1899_CR90","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12974","volume":"18","author":"AR Deussen","year":"2022","unstructured":"Deussen AR, Louise J, Dodd JM. Childhood follow-up of the GRoW randomized trial: Metformin in addition to dietary and lifestyle advice for pregnant women with overweight or obesity. Pediatr Obes. 2022;18(1): e12974.","journal-title":"Pediatr Obes"},{"issue":"4","key":"1899_CR91","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/jc.2017-02419","volume":"103","author":"LGE Hanem","year":"2018","unstructured":"Hanem LGE, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1899_CR92","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","volume":"3","author":"LGE Hanem","year":"2019","unstructured":"Hanem LGE, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166\u201374.","journal-title":"Lancet Child Adolesc Health"},{"issue":"7","key":"1899_CR93","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/00365513.2012.712319","volume":"72","author":"TB R\u00f8","year":"2012","unstructured":"R\u00f8 TB, et al. Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero. Scand J Clin Lab Invest. 2012;72(7):570\u20135.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"1899_CR94","doi-asserted-by":"publisher","first-page":"e1222","DOI":"10.1542\/peds.2012-0346","volume":"130","author":"SM Carlsen","year":"2012","unstructured":"Carlsen SM, Martinussen MP, Vanky E. Metformin\u2019s effect on first-year weight gain: a follow-up study. Pediatrics. 2012;130(5):e1222\u20136.","journal-title":"Pediatrics"},{"issue":"7","key":"1899_CR95","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/1471-0528.12964","volume":"122","author":"H Ij\u00e4s","year":"2015","unstructured":"Ij\u00e4s H, et al. A follow-up of a randomised study of metformin and insulin in gestational diabetes mellitus: growth and development of the children at the age of 18 months. BJOG. 2015;122(7):994\u20131000.","journal-title":"BJOG"},{"key":"1899_CR96","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12887-015-0372-1","volume":"15","author":"MR Battin","year":"2015","unstructured":"Battin MR, et al. Blood pressure measurement at two years in offspring of women randomized to a trial of metformin for GDM: follow up data from the MiG trial. BMC Pediatr. 2015;15:54.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1899_CR97","doi-asserted-by":"publisher","first-page":"e000456","DOI":"10.1136\/bmjdrc-2017-000456","volume":"6","author":"JA Rowan","year":"2018","unstructured":"Rowan JA, et al. Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age. BMJ Open Diabetes Res Care. 2018;6(1):e000456\u2013e000456.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"1899_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056594","volume":"8","author":"H Salom\u00e4ki","year":"2013","unstructured":"Salom\u00e4ki H, et al. Prenatal metformin exposure in mice programs the metabolic phenotype of the offspring during a high fat diet at adulthood. PLoS ONE. 2013;8(2): e56594.","journal-title":"PLoS ONE"},{"issue":"Supplement_1","key":"1899_CR99","doi-asserted-by":"publisher","first-page":"248-OR","DOI":"10.2337\/db22-248-OR","volume":"71","author":"D Feig","year":"2022","unstructured":"Feig D, et al. 248-OR: MiTy kids: follow-up of offspring exposed to metformin in-utero in mothers with type 2 diabetes in the MiTy trial. Diabetes. 2022;71(Supplement_1):248-OR.","journal-title":"Diabetes"},{"issue":"1","key":"1899_CR100","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41398-020-01096-7","volume":"10","author":"K Aviel-Shekler","year":"2020","unstructured":"Aviel-Shekler K, et al. Gestational diabetes induces behavioral and brain gene transcription dysregulation in adult offspring. Transl Psychiatry. 2020;10(1):412.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"1899_CR101","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1038\/s41598-021-84573-3","volume":"11","author":"J Rowland","year":"2021","unstructured":"Rowland J, Wilson CA. The association between gestational diabetes and ASD and ADHD: a systematic review and meta-analysis. Sci Rep. 2021;11(1):5136.","journal-title":"Sci Rep"},{"issue":"9","key":"1899_CR102","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/DBP.0000000000000230","volume":"36","author":"K Tertti","year":"2015","unstructured":"Tertti K, et al. Neurodevelopment of two-year-old children exposed to metformin and insulin in gestational diabetes mellitus. J Dev Behav Pediatr. 2015;36(9):752\u20137.","journal-title":"J Dev Behav Pediatr"},{"issue":"6","key":"1899_CR103","doi-asserted-by":"publisher","first-page":"F488","DOI":"10.1136\/archdischild-2015-309602","volume":"101","author":"TA Wouldes","year":"2016","unstructured":"Wouldes TA, et al. Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes. Arch Dis Child Fetal Neonatal Ed. 2016;101(6):F488-f493.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"1899_CR104","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12887-020-1960-2","volume":"20","author":"HK Greger","year":"2020","unstructured":"Greger HK, et al. Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT. BMC Pediatr. 2020;20(1):60.","journal-title":"BMC Pediatr"},{"issue":"7","key":"1899_CR105","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1471-0528.2010.02763.x","volume":"118","author":"H Ij\u00e4s","year":"2011","unstructured":"Ij\u00e4s H, et al. Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG. 2011;118(7):880\u20135.","journal-title":"BJOG"},{"issue":"1","key":"1899_CR106","doi-asserted-by":"publisher","first-page":"34.e1","DOI":"10.1016\/j.ajog.2013.03.022","volume":"209","author":"CP Spaulonci","year":"2013","unstructured":"Spaulonci CP, et al. Randomized trial of metformin vs insulin in the management of gestational diabetes. Am J Obstet Gynecol. 2013;209(1):34.e1-7.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1899_CR107","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.diabres.2012.09.031","volume":"98","author":"S Niromanesh","year":"2012","unstructured":"Niromanesh S, et al. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pract. 2012;98(3):422\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"1899_CR108","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jog.12950","volume":"42","author":"S Ashoush","year":"2016","unstructured":"Ashoush S, et al. Identification of metformin poor responders, requiring supplemental insulin, during randomization of metformin versus insulin for the control of gestational diabetes mellitus. J Obstet Gynaecol Res. 2016;42(6):640\u20137.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"1899_CR109","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1002\/jcp.27238","volume":"234","author":"N Ghomian","year":"2019","unstructured":"Ghomian N, et al. The efficacy of metformin compared with insulin in regulating blood glucose levels during gestational diabetes mellitus: a randomized clinical trial. J Cell Physiol. 2019;234(4):4695\u2013701.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1899_CR110","doi-asserted-by":"publisher","first-page":"517.e1","DOI":"10.1016\/j.ajog.2021.04.229","volume":"225","author":"MJ Pic\u00f3n-C\u00e9sar","year":"2021","unstructured":"Pic\u00f3n-C\u00e9sar MJ, et al. Metformin for gestational diabetes study: metformin vs insulin in gestational diabetes: glycemic control and obstetrical and perinatal outcomes: randomized prospective trial. Am J Obstet Gynecol. 2021;225(5):517.e1-517.e17.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"1899_CR111","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/ijgo.13718","volume":"156","author":"MP Tew","year":"2022","unstructured":"Tew MP, et al. Metformin in gestational diabetes mellitus: a double-blind placebo-controlled randomized trial. Int J Gynaecol Obstet. 2022;156(3):508\u201315.","journal-title":"Int J Gynaecol Obstet"},{"issue":"23","key":"1899_CR112","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1080\/14767058.2020.1852209","volume":"35","author":"A Dempsey","year":"2022","unstructured":"Dempsey A, et al. Metformin treatment vs a diabetes model of prenatal care in women with mild fasting hyperglycemia diagnosed in pregnancy: a feasibility study. J Matern Fetal Neonatal Med. 2022;35(23):4469\u201377.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"1899_CR113","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015557","volume":"7","author":"D Farrar","year":"2017","unstructured":"Farrar D, et al. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. 2017;7(6): e015557.","journal-title":"BMJ Open"},{"issue":"1","key":"1899_CR114","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/dme.13150","volume":"34","author":"S Butalia","year":"2017","unstructured":"Butalia S, et al. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med. 2017;34(1):27\u201336.","journal-title":"Diabet Med"},{"issue":"1","key":"1899_CR115","first-page":"CD011967","volume":"1","author":"J Brown","year":"2017","unstructured":"Brown J, et al. Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;1(1):CD011967.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1899_CR116","first-page":"CD012037","volume":"11","author":"J Brown","year":"2017","unstructured":"Brown J, et al. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017;11(11):CD012037.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"1899_CR117","first-page":"CD012327","volume":"8","author":"R Martis","year":"2018","unstructured":"Martis R, et al. Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2018;8(8):CD012327.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"1899_CR118","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/jdi.13603","volume":"12","author":"R Bidhendi Yarandi","year":"2021","unstructured":"Bidhendi Yarandi R, et al. Effectiveness of antidiabetic agents for treatment of gestational diabetes: a methodological quality assessment of meta-analyses and network meta-analysis. J Diabetes Investig. 2021;12(12):2247\u201358.","journal-title":"J Diabetes Investig"},{"issue":"16","key":"1899_CR119","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1080\/14767058.2019.1670804","volume":"34","author":"LX Bao","year":"2021","unstructured":"Bao LX, Shi WT, Han YX. Metformin versus insulin for gestational diabetes: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2021;34(16):2741\u201353.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"1899_CR120","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000515893","volume":"86","author":"X Wang","year":"2021","unstructured":"Wang X, et al. Comparison of Insulin, metformin, and glyburide on perinatal complications of gestational diabetes mellitus: a systematic review and meta-analysis. Gynecol Obstet Invest. 2021;86(3):218\u201330.","journal-title":"Gynecol Obstet Invest"},{"key":"1899_CR121","doi-asserted-by":"publisher","first-page":"eRW6155","DOI":"10.31744\/einstein_journal\/2022RW6155","volume":"20","author":"MM Oliveira","year":"2022","unstructured":"Oliveira MM, et al. Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis. Einstein (Sao Paulo). 2022;20:eRW6155.","journal-title":"Einstein (Sao Paulo)"},{"key":"1899_CR122","doi-asserted-by":"publisher","unstructured":"Tertti K, Ekblad U, Koskinen P, Vahlberg T, R\u00f6nnemaa T. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin. Diabetes Obes Metab. 2013;15(3):246\u201351. https:\/\/doi.org\/10.1111\/dom.12017.","DOI":"10.1111\/dom.12017"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01899-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-023-01899-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01899-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T10:43:51Z","timestamp":1688553831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-023-01899-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":122,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1899"],"URL":"https:\/\/doi.org\/10.1007\/s40265-023-01899-0","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"23 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to assist in the preparation of this review. Open Access funding was provided by the IRel. Consortium.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Christine Newman, Louise Rabbitt, Adesuwa Ero and Fidelma P. Dunne have no conflicts of interest to declare in relation to this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analysed during the current study","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"FPD and CN devised the idea for this article. CN and AE performed the literature review. CN, FPD and LR drafted and critically reviewed the work. The authors did not receive support from any organization for the submitted work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}